A citation-based method for searching scientific literature

Torsten Schaller, Nikolas Herold. Curr HIV Res 2016
Times Cited: 4







List of co-cited articles
6 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


SAMHD1 is a barrier to antimetabolite-based cancer therapies.
Sean G Rudd, Torsten Schaller, Nikolas Herold. Mol Cell Oncol 2017
8
50

SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia.
Constanze Schneider, Thomas Oellerich, Hanna-Mari Baldauf, Sarah-Marie Schwarz, Dominique Thomas, Robert Flick, Hanibal Bohnenberger, Lars Kaderali, Lena Stegmann, Anjali Cremer,[...]. Nat Med 2017
63
50

A continuous enzyme-coupled assay for triphosphohydrolase activity of HIV-1 restriction factor SAMHD1.
Laurence H Arnold, Simone Kunzelmann, Martin R Webb, Ian A Taylor. Antimicrob Agents Chemother 2015
28
50

SAMHD1 protects cancer cells from various nucleoside-based antimetabolites.
Nikolas Herold, Sean G Rudd, Kumar Sanjiv, Juliane Kutzner, Julia Bladh, Cynthia B J Paulin, Thomas Helleday, Jan-Inge Henter, Torsten Schaller. Cell Cycle 2017
32
50

Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies.
Nikolas Herold, Sean G Rudd, Linda Ljungblad, Kumar Sanjiv, Ida Hed Myrberg, Cynthia B J Paulin, Yaser Heshmati, Anna Hagenkort, Juliane Kutzner, Brent D G Page,[...]. Nat Med 2017
69
50

The nucleotidohydrolases DCTPP1 and dUTPase are involved in the cellular response to decitabine.
Cristina E Requena, Guiomar Pérez-Moreno, András Horváth, Beáta G Vértessy, Luis M Ruiz-Pérez, Dolores González-Pacanowska, Antonio E Vidal. Biochem J 2016
14
50


A Comparative Systematic Review of the Optimal CD4 Cell Count Threshold for HIV Treatment Initiation.
Babatunde Olubajo, Kathryn Mitchell-Fearon, Oluseye Ogunmoroti. Interdiscip Perspect Infect Dis 2014
11
25


Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans.
Sarah Nanzigu, Ronald Kiguba, Joseph Kabanda, Jackson K Mukonzo, Paul Waako, Cissy Kityo, Fred Makumbi. HIV AIDS (Auckl) 2013
10
25


The problem of late ART initiation in Sub-Saharan Africa: a transient aspect of scale-up or a long-term phenomenon?
Maria Lahuerta, Frances Ue, Susie Hoffman, Batya Elul, Sarah Gorrell Kulkarni, Yingfeng Wu, Harriet Nuwagaba-Biribonwoha, Robert H Remien, Wafaa El Sadr, Denis Nash. J Health Care Poor Underserved 2013
73
25

Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.
Sara Lodi, Andrew Phillips, Roger Logan, Ashley Olson, Dominique Costagliola, Sophie Abgrall, Ard van Sighem, Peter Reiss, José M Miró, Elena Ferrer,[...]. Lancet HIV 2015
39
25

Genetic polymorphisms of Fas (CD95) and Fas ligand (CD178) influence the rise in CD4+ T cell count after antiretroviral therapy in drug-naïve HIV-positive patients.
Milena Nasi, Marcello Pinti, Roberto Bugarini, Leonarda Troiano, Enrico Lugli, Cristian Bellodi, Cristina Mussini, Vanni Borghi, Tommaso Trenti, Fiorella Balli,[...]. Immunogenetics 2005
38
25

Virologic and immunologic response to HAART, by age and regimen class.
Keri N Althoff, Amy C Justice, Stephen J Gange, Steven G Deeks, Michael S Saag, Michael J Silverberg, M John Gill, Bryan Lau, Sonia Napravnik, Ellen Tedaldi,[...]. AIDS 2010
88
25

The next generation of the World Health Organization's global antiretroviral guidance.
Gottfried Hirnschall, Anthony D Harries, Philippa J Easterbrook, Meg C Doherty, Andrew Ball. J Int AIDS Soc 2013
50
25

Immunological failure despite virological suppression in HIV seropositive individuals on antiretroviral therapy.
B Prabhakar, Asima Banu, H B Pavithra, P Chandrashekhara, Suresh Sasthri. Indian J Sex Transm Dis AIDS 2011
16
25


Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia.
Amanda Mocroft, Andrew N Phillips, Bruno Ledergerber, Christine Katlama, Antonio Chiesi, Frank-Detlef Goebel, Brygioa Knysz, Francisco Antunes, Peter Reiss, Jens D Lundgren. AIDS 2006
35
25

When and why to start antiretroviral therapy?
Jose M Gatell. J Antimicrob Chemother 2010
6
25

Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India.
A J Kandathil, R Kannangai, V P Verghese, S A Pulimood, P Rupali, G Sridharan, P Grant, D Pillay, O C Abraham. Indian J Med Microbiol 2009
13
25

HIV/AIDS Clinical Manifestations and their Implication for Patient Clinical Staging in Resource Limited Settings in Tanzania.
Idindili Boniphace, Minzi Omari, Rumisha Susan Fred, Mugusi Ferdinand, Tanner Marcel. Open AIDS J 2011
4
25

Changes in first-line cART regimens and short-term clinical outcome between 1996 and 2010 in The Netherlands.
Mikaela Smit, Colette Smit, Suzanne Geerlings, Luuk Gras, Kees Brinkman, Timothy B Hallett, Frank de Wolf. PLoS One 2013
11
25

Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery.
Frederik N Engsig, Robert Zangerle, Olga Katsarou, Francois Dabis, Peter Reiss, John Gill, Kholoud Porter, Caroline Sabin, Andrew Riordan, Gerd Fätkenheuer,[...]. Clin Infect Dis 2014
93
25

IMMUNOLOGICAL PROFILES IN HIV POSITIVE PATIENTS FOLLOWING HAART INITIATION IN KIGALI, RWANDA.
A P Twizerimana, J Mwatha, J P Musabyimana, E Kayigi, J De Dieu Harelimana, S M Karanja, L Mutesa. East Afr Med J 2014
4
25


Phosphorylation of mouse SAMHD1 regulates its restriction of human immunodeficiency virus type 1 infection, but not murine leukemia virus infection.
Feifei Wang, Corine St Gelais, Suresh de Silva, Hong Zhang, Yu Geng, Caitlin Shepard, Baek Kim, Jacob S Yount, Li Wu. Virology 2016
20
25

Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein.
Kasia Hrecka, Caili Hao, Magda Gierszewska, Selene K Swanson, Malgorzata Kesik-Brodacka, Smita Srivastava, Laurence Florens, Michael P Washburn, Jacek Skowronski. Nature 2011
836
25

SAMHD1 specifically restricts retroviruses through its RNase activity.
Jongsu Choi, Jeongmin Ryoo, Changhoon Oh, Sungyeon Hwang, Kwangseog Ahn. Retrovirology 2015
54
25


Substrates and Inhibitors of SAMHD1.
Joseph A Hollenbaugh, Jadd Shelton, Sijia Tao, Sheida Amiralaei, Peng Liu, Xiao Lu, Russell W Goetze, Longhu Zhou, James H Nettles, Raymond F Schinazi,[...]. PLoS One 2017
31
25

Heterozygous colon cancer-associated mutations of SAMHD1 have functional significance.
Matilda Rentoft, Kristoffer Lindell, Phong Tran, Anna Lena Chabes, Robert J Buckland, Danielle L Watt, Lisette Marjavaara, Anna Karin Nilsson, Beatrice Melin, Johan Trygg,[...]. Proc Natl Acad Sci U S A 2016
65
25

A G1-like state allows HIV-1 to bypass SAMHD1 restriction in macrophages.
Petra Mlcochova, Katherine A Sutherland, Sarah A Watters, Cosetta Bertoli, Rob Am de Bruin, Jan Rehwinkel, Stuart J Neil, Gina M Lenzi, Baek Kim, Asim Khwaja,[...]. EMBO J 2017
50
25

An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
Yangyang Bian, Chunxia Song, Kai Cheng, Mingming Dong, Fangjun Wang, Junfeng Huang, Deguang Sun, Liming Wang, Mingliang Ye, Hanfa Zou. J Proteomics 2014
148
25


Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1.
Yanick J Crow, Diana S Chase, Johanna Lowenstein Schmidt, Marcin Szynkiewicz, Gabriella M A Forte, Hannah L Gornall, Anthony Oojageer, Beverley Anderson, Amy Pizzino, Guy Helman,[...]. Am J Med Genet A 2015
288
25


HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase.
David C Goldstone, Valerie Ennis-Adeniran, Joseph J Hedden, Harriet C T Groom, Gillian I Rice, Evangelos Christodoulou, Philip A Walker, Geoff Kelly, Lesley F Haire, Melvyn W Yap,[...]. Nature 2011
554
25

The role of reactive oxygen species and metabolism on cancer cells and their microenvironment.
Ana Costa, Alix Scholer-Dahirel, Fatima Mechta-Grigoriou. Semin Cancer Biol 2014
167
25

The deoxynucleotide triphosphohydrolase SAMHD1 is a major regulator of DNA precursor pools in mammalian cells.
Elisa Franzolin, Giovanna Pontarin, Chiara Rampazzo, Cristina Miazzi, Paola Ferraro, Elisa Palumbo, Peter Reichard, Vera Bianchi. Proc Natl Acad Sci U S A 2013
154
25


SAMHD1: a new gene for CLL.
Davide Rossi. Blood 2014
10
25


A Highly Active Isoform of Lentivirus Restriction Factor SAMHD1 in Mouse.
Nicolin Bloch, Sabine Gläsker, Poojitha Sitaram, Henning Hofmann, Caitlin N Shepard, Megan L Schultz, Baek Kim, Nathaniel R Landau. J Biol Chem 2017
13
25


SAMHD1-mediated HIV-1 restriction in cells does not involve ribonuclease activity.
Jenna M Antonucci, Corine St Gelais, Suresh de Silva, Jacob S Yount, Chenxiang Tang, Xiaoyun Ji, Caitlin Shepard, Yong Xiong, Baek Kim, Li Wu. Nat Med 2016
56
25

SAMHD1 is a single-stranded nucleic acid binding protein with no active site-associated nuclease activity.
Kyle J Seamon, Zhiqiang Sun, Luda S Shlyakhtenko, Yuri L Lyubchenko, James T Stivers. Nucleic Acids Res 2015
83
25


Toward a comprehensive characterization of a human cancer cell phosphoproteome.
Houjiang Zhou, Serena Di Palma, Christian Preisinger, Mao Peng, Ayse Nur Polat, Albert J R Heck, Shabaz Mohammed. J Proteome Res 2013
250
25

Randomized trial of TAS-102 for refractory metastatic colorectal cancer.
Robert J Mayer, Eric Van Cutsem, Alfredo Falcone, Takayuki Yoshino, Rocio Garcia-Carbonero, Nobuyuki Mizunuma, Kentaro Yamazaki, Yasuhiro Shimada, Josep Tabernero, Yoshito Komatsu,[...]. N Engl J Med 2015
606
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.